Skip to content

Standard Chinese medicine as primary?

Page last modified on: October 2, 2008
Question from Christine: My associate is using TCM (Traditional Chinese Medicine) as her primary therapy for breast cancer. Is there any kind of "standard" for use of TCM either before or after surgery?
Answer —Raymond Chang, M.D.: There is no standard. It's highly individualized. It depends on the practitioner and the patient.

On Wednesday, September 21, 2005, our Ask-the-Expert Online Conference was called Traditional Chinese MedicineRaymond Chang, M.D. and moderator Beth Baughman Dupree, M.D., F.A.C.S. answered your questions about how to discuss Traditional Chinese Medicine (TCM) with your cancer doctor.


The materials presented in these conferences do not necessarily reflect the views of breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.

A production of LiveWorld, Inc.
Copyright 2008. All rights reserved.

Email Updates

Stay informed about current research, online events, and more.

Please leave this field empty

Meet the Experts

Raymond Chang, M.D. is an internationally respected physician-acupuncturist uniquely trained in traditional Chinese medicine as well as contemporary Western medicine, and he is an acknowledged pioneer-specialist in integrative programs for cancer, infertility, and other difficult-to-treat conditions.

Beth Baughman DuPree, M.D., F.A.C.S.Beth Baughman DuPree, M.D., F.A.C.S. is a general surgeon. Her clinical practice is located at Holy Redeemer Hospital and St. Mary Medical Center.

Back to top

Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003

Learn more about our commitment to your privacy

© 2009 Breastcancer.org - All rights reserved.

Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.